These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6546809)

  • 1. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide.
    Watkins LR; Kinscheck IB; Mayer DJ
    Science; 1984 Apr; 224(4647):395-6. PubMed ID: 6546809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist.
    Price DD; von der Gruen A; Miller J; Rafii A; Price C
    Anesth Analg; 1985 Aug; 64(8):801-6. PubMed ID: 4014744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates.
    Watkins LR; Kinscheck IB; Kaufman EF; Miller J; Frenk H; Mayer DJ
    Brain Res; 1985 Feb; 327(1-2):181-90. PubMed ID: 3838691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide.
    Watkins LR; Kinscheck IB; Mayer DJ
    Brain Res; 1985 Feb; 327(1-2):169-80. PubMed ID: 3838690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proglumide prevents and curtails acute tolerance to morphine in rats.
    Tang J; Chou J; Iadarola M; Yang HY; Costa E
    Neuropharmacology; 1984 Jun; 23(6):715-8. PubMed ID: 6462377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proglumide selectively potentiates supraspinal mu 1 opioid analgesia in mice.
    Bodnar RJ; Paul D; Pasternak GW
    Neuropharmacology; 1990 May; 29(5):507-10. PubMed ID: 2162497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of proglumide on morphine induced motility changes.
    Ben-Horin N; Ben-Horin E; Frenk H
    Psychopharmacology (Berl); 1984; 84(4):541-3. PubMed ID: 6441955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
    Kellstein DE; Mayer DJ
    Brain Res; 1990 May; 516(2):263-70. PubMed ID: 2364292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of beta-endorphin effects by proglumide in rats.
    Katsuura G; Itoh S
    Eur J Pharmacol; 1985 Jan; 107(3):363-6. PubMed ID: 3156751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possible potentiation of morphine analgesia by proglumide].
    Pagnoni B; Ortalli G; Rovati LC; Tiengo M
    Minerva Anestesiol; 1988 Apr; 54(4):131-6. PubMed ID: 3211341
    [No Abstract]   [Full Text] [Related]  

  • 11. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia.
    Benedetti F
    Pain; 1996 Mar; 64(3):535-543. PubMed ID: 8783319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple endogenous opiate and non-opiate analgesia systems: evidence of their existence and clinical implications.
    Watkins LR; Mayer DJ
    Ann N Y Acad Sci; 1986; 467():273-99. PubMed ID: 3014973
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cholecystokinin antagonist (proglumide) potentiates the inhibitory effect of morphine on micturition reflex].
    Hisamitsu T; Okada M
    Masui; 1987 Jun; 36(6):852-6. PubMed ID: 3656653
    [No Abstract]   [Full Text] [Related]  

  • 14. The nature of conditioned anti-analgesia: spinal cord opiate and anti-opiate neurochemistry.
    Wiertelak EP; Yang HY; Mooney-Heiberger K; Maier SF; Watkins LR
    Brain Res; 1994 Jan; 634(2):214-26. PubMed ID: 8131071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal co-administration of cholecystokinin antagonists with morphine prevents the development of opioid tolerance.
    Kellstein DE; Mayer DJ
    Pain; 1991 Nov; 47(2):221-229. PubMed ID: 1762818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of tolerance and dependence to morphine: a possible role for cholecystokinin.
    Panerai AE; Rovati LC; Cocco E; Sacerdote P; Mantegazza P
    Brain Res; 1987 Apr; 410(1):52-60. PubMed ID: 3580899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin-octapeptide antagonizes morphine analgesia in periaqueductal gray of the rat.
    Li Y; Han JS
    Brain Res; 1989 Feb; 480(1-2):105-10. PubMed ID: 2713644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo studies on spinal opiate receptor systems mediating antinociception. I. Mu and delta receptor profiles in the primate.
    Yaksh TL
    J Pharmacol Exp Ther; 1983 Aug; 226(2):303-16. PubMed ID: 6308205
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mutual potentiation of the analgesic effects of [MET5] enkephalin, dynorphin A-(1-13) and morphine in the spinal cord of the rat].
    Huang L; Ren MF; Lu JH; Han JS
    Sheng Li Xue Bao; 1987 Oct; 39(5):454-61. PubMed ID: 2898811
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholecystokinin antianalgesia: safety cues abolish morphine analgesia.
    Wiertelak EP; Maier SF; Watkins LR
    Science; 1992 May; 256(5058):830-3. PubMed ID: 1589765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.